Testing effectiveness (Phase 2)Study completedNCT02547805
What this trial is testing
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
Who this might be right for
Secondary HyperoxaluriaNephrolithiasisHyperoxaluria+2 more
Allena Pharmaceuticals 66